Drug Development Market Reports

Find the information you need on pharmaceutical drug development. The Kalorama Information collection of research reports provides insights into product and market trends, analyses, opportunities, projections, and marketing strategies. Specifics on market share, size, and growth in US and global drug development markets are also featured.

Title	Published	Price
Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition Driven by mounting market pressures, companies are increasingly implementing outsourcing strategies to increase revenues through faster drug development. By decreasing their in-house facilities and staff, and outsourcing more of their R&D functions, pharmaceutical and biotechnology companies are reshaping the drug development services industry. Kalorama Information's Outsourcing in Drug Development is  |  more...	Oct 1, 2008	$3,500.00
The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends) Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 years after age 65. Incidence of the disease is increasing, and the resulting attention given to Alzheimer's Disease has encouraged development of new treatments.  |  more...	Aug 1, 2008	$2,995.00
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition 2008 has seen no decrease in the opportunities available for outsourcing drug discovery, for a number of reasons. New technologies increase the number of targets and accelerate the identification of active compounds. There is increasing pressure to develop new lead compounds due to the near-term loss of patent  |  more...	May 1, 2008	$3,500.00
Pharmaceutical Excipients for Oral Formulations, 2nd. Edition Pharmaceutical excipients are substances, other than the pharmacologically active drug or prodrug, which are included in the manufacturing process or are contained in the finished pharmaceutical product dosage form. Excipients provide enhanced functionality to the pharmaceuticals, aid the innovations in the drug development and help improve patent life as well.  |  more... Search inside this report	Feb 1, 2008	$3,995.00
Offshoring Clinical Trials (The Market for Clinical Trials in India, China, Mexico, Brazil, Russia and Israel.) Offshoring of clinical trials is increasing as companies in the U.S. are finding challenges in clinical trial research ranging from cost, patient recruitment, patient compliance during participation, qualified professionals, new clinical trial patients, and other problems. This provides an opportunity for BRIC countries and other developing regions to grab  |  more...	Nov 1, 2007	$3,500.00
Anesthesia Drugs: Worldwide Markets An understanding of the market for anesthesia could be worthwhile to any pharmaceutical marketer and any equity company investing or consulting in this area. Anesthesia markets are in one sense simple: growth in these drugs are correlated to prevalence and incidence in disease, and the resulting increase in procedure  |  more... Search inside this report	Jul 1, 2007	$2,995.00
Early Toxicology: Markets and Approaches Toxicity is a crucial parameter that is measured throughout the drug development process. Toxic side-effects are one of the most common reasons drug candidates fail. Toxicity can be a factor of dose, the form in which the drug is administered, and the time of exposure before elimination. Patient  |  more...	Jun 1, 2007	$3,495.00
Biomarkers: A Market Briefing Personalized medicine, the use of therapies that are targeted to the individual patient, is a reality today, thanks to a growing emphasis on biomarker research. Biomarkers promise a smoother integration of diagnostics and therapeutics, and most importantly a reduction in time and cost for Phase I and II clinical trials.  |  more... Search inside this report	Jan 1, 2007	$1,995.00
Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs, World Market The market for psychotherapeutics drugs is about to change dramatically -- and serious pharmaceutical market watchers will want to be prepared. Kalorama’s Psychotherapeutics: Antidepressants, Antipsychotics, Antianxiety Drugs: World Market is the most exhaustive guide available to this booming market and the direction it is  |  more... Buy by the section | Search inside this report	Jan 1, 2007	$3,500.00
Outsourcing in Drug Development: The Contract Research (CRO) Market, 2nd Edition CRO is a need-to know practice in pharmaceutical marketing today; but information is not always easy to find. This second edition of Kalorama’s best-selling look at the clinical contract research industry provides the key information competitors need to navigate the complexities and costs of clinical research in the drug  |  more... Buy by the section | Search inside this report	May 1, 2006	$3,500.00
Men's Health: The Market for Current and Emerging Drug Therapies, 2nd Edition This complete re-evaluation of the Men’s Health market focuses on the following prescription drug treatment segments: Men’s Cancer Men’s Sexual Dysfunction Men’s Sexually Transmitted Diseases Men’s Urinary Conditions Andropause The report covers drugs used for the treatment of prostate cancer, testicular cancer, impotence, premature ejaculation, and benign prostatic  |  more... Buy by the section | Search inside this report	May 1, 2006	$3,550.00
Transgenic Animals and Plants in Pharmaceutical Research and Manufacturing With the mapping of the human genome and the concomitant explosion of proteomics, a steady stream of biopharmaceuticals have been launched—recombinant therapeutic proteins, monoclonal antibody-based products used for therapeutic or in vivo diagnostic purposes, and nucleic acid-based products. As the rate of regulatory approval for biopharmaceuticals increases, the  |  more... Buy by the section | Search inside this report	Jan 1, 2006	$2,995.00
Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications The concept of nucleic acid-based therapeutics is not a new one. For a long time it has been thought that molecules similar to those that make up our genetic structure would make effective therapeutics. It is an idea whose time has come. There are six types of nucleic acid-based  |  more... Buy by the section | Search inside this report	Jan 1, 2005	$3,500.00
Early Stage Drug Discovery 2004: Combi-chem & High Throughput Screening Revisited Ten years ago, high throughput screening (HTS) was being touted as the answer to improving productivity in drug discovery. If screening thousands of compounds a week was good, screening hundreds of thousands would be even better. This led to the boom in Ultra HTS (UHTS), manufacturing-scale systems, and  |  more... Buy by the section | Search inside this report	Jun 1, 2004	$2,995.00
Outsourcing in Drug Discovery The number and scope of drug discovery outsourcing agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part of drug discovery. Major pharmas and biotechs are aggressively pursuing a range of outsourcing agreements.  |  more... Buy by the section | Search inside this report	May 1, 2003	$2,062.00
Enabling Technologies in Drug Discovery Research Package Kalorama's Proteomics 50: Competing Technologies & Alliances in an Emerging Industry November 2001 Abstract : With the Human Genome Project in its culminating phase, scientists are turning to the task of converting the soon to be completed DNA sequence into information that will improve human medicine and health care. One  |  more... Search inside this report	Sep 1, 2002	$2,999.00
Diabetes and Diabetic Complications: Major World Markets The global market for diabetes products, particularly new therapeutics and monitoring products, is a large and growing one. This growth is fueled by three factors --- (1) a rapidly increasing patient population; (2) a back-log of unmet needs, particularly with regard to therapeutics; and (3) advances in biomedical  |  more... Buy by the section | Search inside this report	Jan 1, 2002	$2,625.00
Kalorama's Proteomics 50: Competing Technologies and Alliances in an Emerging Industry With the Human Genome Project in its culminating phase, scientists are turning to the task of converting the soon to be completed DNA sequence into information that will improve human medicine and health care. One of the key challenges ahead is understanding how proteins direct biological functions. Proteomics, the  |  more... Buy by the section | Search inside this report	Nov 1, 2001	$1,497.00
New Pharmaceutical Distribution Channels: Emerging Markets for 10 Leading Drug Classes This Kalorama Information report analyzes the changes taking place in distributing pharmaceutical products for six channels: ambulatory care centers, government programs, health maintenance organizations, hospitals, long-term care centers, and mail service pharmacies. Sales of the following ten drug categories are assessed and quantified: anti-infective, asthma drugs, cancer therapeutics, cardiovascular drugs,  |  more... Search inside this report	Oct 1, 1995	$1,625.00
Alternative Drug Delivery Systems This report from Kalorama Information focuses on various drug delivery technologies in use today and addresses the products that will be available in the near future. The report identifies new systems, advances and innovative companies. The systems featured are those that deliver therapeutic doses to selective targets, with  |  more... Search inside this report	Sep 1, 1995	$1,625.00
Market For Monoclonal Antibodies [MABs] Once dubbed the magic bullet for treating cancer and other complex diseases, monoclonal antibodies are entering a period of tremendous growth potential. This comprehensive new report by Kalorama Information discusses the latest advances and the critical role MABs will play in the future. Explains which new MABs  |  more... Search inside this report	Jul 1, 1995	$1,625.00
Title	Published	Price